World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
197
Citations
166271
World Ranking
326
National Ranking
217

Medicine

D-Index
198
Citations
174564
World Ranking
193
National Ranking
129

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

David Cella is affiliated with Northwestern University in the United States and has a substantial body of research primarily in the field of medicine, with a significant focus on oncology. Their work spans several subfields including oncology, economics and econometrics, pulmonary and respiratory medicine, pediatrics, perinatology and child health, as well as public health, environmental and occupational health.

The research contributions by David Cella extensively cover topics related to cancer survivorship and care, health systems, economic evaluations and quality of life, childhood cancer survivors' quality of life, economic and financial impacts of cancer, cancer treatment and pharmacology, renal cell carcinoma treatment, and palliative care and end-of-life issues.

Examples of recent papers by David Cella include:

  • Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures, 2021, Quality of Life Research
  • Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial, 2020, Cancer
  • Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer, 2022, JAMA
  • Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209), 2020, Journal of Clinical Oncology
  • The increasing value of eHealth in the delivery of patient-centred cancer care, 2020, The Lancet Oncology

Frequent collaborators in their research include John Devin Peipert, Richard Gershon, Sofia F. Garcia, Lynne I. Wagner, and Lisa P. Jacobson.

Key publication venues where David Cella has frequently contributed are:

  • Journal of Clinical Oncology
  • UNC Libraries
  • Quality of Life Research
  • Journal of Patient-Reported Outcomes
  • Cancer

David Cella's research output is characterized by a multidisciplinary approach combining clinical oncology with economic and quality-of-life assessments, reflecting the interconnected nature of modern medical research. Their scholarly activity in both clinical and patient-reported outcome measures demonstrates a focus on both treatment efficacy and patient-centered care paradigms.

Best Publications

  • The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

    D F Cella;D S Tulsky;G Gray;B Sarafian

  • The patient-reported outcomes measurement information system (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008

    David Cella;William Riley;Arthur Stone;Nan Rothrock

  • Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer

    Kathy Miller;Molin Wang;Julie Gralow;Maura Dickler

  • Interpreting the Clinical Importance of Treatment Outcomes in Chronic Pain Clinical Trials: IMMPACT Recommendations

    Robert H. Dworkin;Dennis C. Turk;Kathleen W. Wyrwich;Dorcas Beaton

  • Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial

    Mark G. Kris;Ronald B. Natale;Roy S. Herbst;Thomas J. Lynch

  • The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH Roadmap cooperative group during its first two years.

    David Cella;Susan Yount;Susan Yount;Nan Rothrock;Richard Gershon;Richard Gershon

  • Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS®): depression, anxiety, and anger.

    Paul A. Pilkonis;Seung W. Choi;Steven P. Reise;Angela M. Stover

  • Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes.

    Dennis A. Revicki;Ron D. Hays;David Cella;Jeff A. Sloan

  • Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma

    Robert J. Motzer;Thomas E. Hutson;David Cella;James Reeves

  • Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

    Brian I. Rini;Bernard Escudier;Piotr Tomczak;Andrey Kaprin

  • Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system

    Suzanne B. Yellen;David F. Cella;Kimberly Webster;Carol Blendowski

  • Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items

    Ron D. Hays;Jakob B. Bjorner;Dennis A. Revicki;Karen L. Spritzer

  • Measuring spiritual well-being in people with cancer: the functional assessment of chronic illness therapy--Spiritual Well-being Scale (FACIT-Sp).

    Amy H. Peterman;George Fitchett;Marianne J. Brady;Lesbia Hernandez

  • Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

    M J Brady;D F Cella;F Mo;A E Bonomi

  • Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue Coalition

    Gregory A. Curt;William Breitbart;David Cella;Jerome E. Groopman

  • Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

    Bryce B. Reeve;Ron D. Hays;Jakob B. Bjorner;Karon F. Cook

  • The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation

    Kimberly Webster;David Cella;Kathleen Yost

  • Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.

    J. Douglas Rizzo;Alan E. Lichtin;Steven H. Woolf;Jerome Seidenfeld

  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Stephen Tyring;Alice Gottlieb;Kim Papp;Ken Gordon

  • Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non-Small Cell Lung Cancer

    Mark G. Kris;Ronald B. Natale;Roy S. Herbst;Diane Prager

Frequent Co-Authors

Jin Shei Lai
Jin Shei Lai Northwestern University
Elizabeth A. Hahn
Elizabeth A. Hahn Northwestern University
Ron D. Hays
Ron D. Hays University of California, Los Angeles
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
Allen W. Heinemann
Allen W. Heinemann Northwestern University
Richard Gershon
Richard Gershon Northwestern University
Seung W. Choi
Seung W. Choi The University of Texas at Austin
Karon F. Cook
Karon F. Cook Northwestern University
Bryce B. Reeve
Bryce B. Reeve Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in healthcare careers beyond traditional MD and DO programs, there are many alternative pathways to consider. For aspiring nurses, there are direct msn programs online designed for candidates with a non-nursing background. These accelerated options can lead to advanced practice roles more quickly.

Alternatively, those seeking a faster route to patient care roles might explore adn programs, which allow students to become registered nurses in as little as two years. Some schools offer flexible entry requirements and rolling admissions, opening doors for a broader range of applicants.

If working directly with patients isn’t your goal, consider enrolling in medical coding and billing classes online with financial aid. These programs prepare you for essential behind-the-scenes roles in the healthcare system and often offer job-ready training in a year or less.

Concerned about admissions tests? Some nursing schools do not require the TEAS or HESI exams. Learn more: do you have to take a teas test for lpn.

Best Scientists Citing David Cella

Trending Scientists